Clik here to view.
NHF 70th: Pursuing Discovery of the Next Generation of Therapies
An interview with one of the recipients of NHF's Innovative Investigator AwardsRead more about NHF 70th: Pursuing Discovery of the Next Generation of Therapies
View ArticleClik here to view.
Catalyst Updates on Phase 2/3 Trial of Subcutaneous Therapy
Catalyst Biosciences recently announced updated positive interim data from a phase 2/3, multinational clinical study of marzeptacog alfa (MarzAA), a subcutaneously administered factor VIIa therapy....
View ArticleClik here to view.
uniQure Confirms First Patient Dosed in Hemophilia B Gene Therapy Study with...
The therapy is for people with severe and moderately severe hemophilia B.Read more about uniQure Confirms First Patient Dosed in Hemophilia B Gene Therapy Study with AMT-061
View ArticleClik here to view.
New 3500 IU Vial Size Now Available for Idelvion®
The new vial size will reduce the reconstitution time that was needed to prepare multiple vials for a similar dose.Read more about New 3500 IU Vial Size Now Available for Idelvion®
View ArticleClik here to view.
Bayer receives FDA approval for hemophilia A treatment Jivi®
Bayer received FDA approval for new extended half-life hemophilia A product for patients 12 yrs and older.Read more about Bayer receives FDA approval for hemophilia A treatment Jivi®
View ArticleClik here to view.
New Medscape Activity Makes the Case for Gene Therapy
By accessing this activity healthcare providers will increase their knowledge of the potential role of gene therapy to address challenges in current hemophilia treatment.Read more about New Medscape...
View ArticleClik here to view.
San Diego HTC Looks at Cardiovascular Disease in Young People with Hemophilia
Investigators study early risk factors and prevention of cardiovascular disease in children and young adults with hemophilia.Read more about San Diego HTC Looks at Cardiovascular Disease in Young...
View ArticleClik here to view.
NHLBI Seeking Public Input to Drive FVIII Inhibitor Research
Provide your input today and you will be helping to guide the critical future of inhibitor research.Read more about NHLBI Seeking Public Input to Drive FVIII Inhibitor Research
View ArticleClik here to view.
Copay Accumulator Adjustments: What are they and how they can affect you
Watch this video to learn how Copay accumulator adjustments affect patients requiring specialty medications with no generic alternatives.Read more about Copay Accumulator Adjustments: What are they and...
View ArticleHANDI Highlights: Resources for Tackling Life’s Many Transitions!
Fall is upon us as crisper, cooler weather prevails across much of the country. It is arguably the season most evocative of change, and in that spirit NHF’s information resource center HANDI would like...
View ArticleNHF Announces NHF-Shire Clinical Fellowship Award Recipients for 2018
The National Hemophilia Foundation (NHF) is pleased to announce the 2018 NHF-Shire Clinical Fellowship award recipients: Hanny Al-Samkari, MD, of Boston Hemophilia Center/Massachusetts General Hospital...
View ArticleClik here to view.
Hemlibra® Receives Expanded FDA Approval for Hemophilia A Patients Without...
The Genentech therapy has been approved for routine prophylaxis in adults and children with or without factor VIII inhibitors.Read more about Hemlibra® Receives Expanded FDA Approval for Hemophilia A...
View ArticleClik here to view.
NHF, WFH, EHC Monitor Coronavirus Impact on Bleeding Disorders Community
The organizations continue to monitor the outbreak.Read more about NHF, WFH, EHC Monitor Coronavirus Impact on Bleeding Disorders Community
View ArticleClik here to view.
NHF Awarded 4-star Rating from Charity Navigator
NHF maintains its prestigious 4-star rating from Charity Navigator, the largest independent charity evaluator in the US.Read more about NHF Awarded 4-star Rating from Charity Navigator
View ArticleClik here to view.
Novo Nordisk Announces Launch of New Factor VIII Therapy
ESPEROCT® is a long-acting recombinant product for the treatment of hemophilia A.Read more about Novo Nordisk Announces Launch of New Factor VIII Therapy
View ArticleClik here to view.
How FDA is Putting the Patient Voice at the Forefront of Gene Therapy...
The impact of an FDA "Listening Session" on gene therapy for hemophilia.Read more about How FDA is Putting the Patient Voice at the Forefront of Gene Therapy Clinical Trials for Hemophilia
View ArticleClik here to view.
Emergency Department Guidelines Now Available in Multiple Formats
This resource will provide much-needed guidance to emergency department personnel.Read more about Emergency Department Guidelines Now Available in Multiple Formats
View ArticleClik here to view.
NHF Announces 2020 Physical Therapy Excellence Fellowship Award
The Physical Therapy Excellence Fellowship supports PTs in their research or clinical projects related to the care of patients with hemophilia.Read more about NHF Announces 2020 Physical Therapy...
View ArticleClik here to view.
Letter to Our Community
Collaboration will unlock our potential and define our success.Read more about Letter to Our Community
View ArticleClik here to view.
Partners in Bleeding Disorders Education Program Launches Revised Module
This is a six-part activity designed to increase healthcare providers' knowledge of the treatment of hemophilia.Read more about Partners in Bleeding Disorders Education Program Launches Revised Module
View Article